Donald G. Klepser, PhD, MBA

Donald G. Klepser, PhD, MBA

Professor and Associate Dean for Academic Affairs

Department of Pharmacy Practice and Science
College of Pharmacy
University of Nebraska Medical Center
986120 Nebraska Medical Center
Omaha, NE 68198-6120
402-559-4927 (Office)
402-559-5673 (Fax)
Email
 
Teaching Activities: 
Dr. Klepser is the primary instructor and course coordinator for Pharmacy Practice Management (PHPR 662), which is required during the first semester of the third professional year. Dr. Klepser has also developed and coordinates two elective courses, Managed Care Pharmacy (PHPR 643) Pharmacy Practice Research Elective (PHPR 663) for third year pharmacy students and an accompanying research experience in the fourth year that provides an introduction to the research process.

Research Activities/Interests:  
Dr. Klepser’s areas of interest include healthcare policy, pharmacoeconomics, and outcomes research. His current research is in the areas of point-of-care testing and diseases management service in community pharmacies, the expanded role for pharmacists in the changing healthcare environment, rural pharmacy access, cost containment, and managed care benefit design. Dr. Klepser has presented his research in these areas at national and international meetings and has numerous peer reviewed publications.

Recent Publications:

  1. Klepser DG, Klepser NS, Adams JL, Adams AJ, Klepser ME. “The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing.” Expert Review of Molecular Diagnostics. 2021 Jun 15. doi:10.1080/14737159.2021.1944105.  Online ahead of print.
  2. Klepser NS, Klepser DG, Adams JL, Adams AJ, Klepser MK. “Impact of COVID-19 on prevalence of community pharmacies as CLIA-Waived facilities.” Research in Social and Administrative Pharmacy.  2021:17:1574-1578. https://doi.org/10.1016/j.sapharm.2020.12.003
  3. Hopkins R, Josma D, Morris J, Klepser DG, Young HN, Crawford ND. “Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists.” J Am Pharm Assoc (2003). 2020 Nov 16:S1544-3191(20)30489-1. doi: 10.1016/j.japh.2020.10.005.
  4. Cochran GL, Foster JA, Klepser DG, Dobesh PP, Dering-Anderson AM. “The impact of eliminating backward navigation on computerized exam scores and completion time.” American Journal of Pharmaceutical Education October 2020, ajpe8034; DOI: https://doi.org/10.5688/ajpe8034
  5. Klepser DG, Klepser ME, Murry JS, Borden H, Olsen KM. “Evaluation of a Community Pharmacy-Based Influenza and Group A Streptococcal Pharyngitis Disease Management Program Using Polymerase Chain Reaction Point-of-Care Testing.” Journal of the American Pharmacist Association.  2019:59:872-879.
  6. Klepser DG, Klepser ME.  “Point-of-Care testing in the pharmacy: how is the field advancing.”  Expert Review of Molecular Diagnostics. 2018:18:5-6
  7. Klepser DG, Klepser ME, Smith JK, Dering-Anderson AM, Nelson M, Pohren LE.  “Utilization of Influenza and Streptococcal Pharyngitis Point-of-Care Testing in the Community Pharmacy Practice Setting.”  Research in Social and Administrative Pharmacy. 2018:14:356-359. 
  8. Corn CE, Klepser DG, Dering-Anderson AM, Brown TG, Klepser ME, Smith JK, “Observation of a Pharmacist Conducted Group A Streptococcal Pharyngitis Point-of-Care Test:  A Time and Motion Study.”  Journal of Pharmacy Practice. 2018:31:284-291.
  9. Klepser DG, Klepser ME, Dering-Anderson AM, Morse JA, Smith JK, Klepser SA.  “Implementation and evaluation of an innovative pharmacist-physician collaborative group A steptococcus disease state management program.” Journal of the American Pharmacist Association.  2016;56:323-329.
  10. Klepser ME, Klepser DG, Dering-Anderson AM, Morse JA, Smith JK, Klepser SA.  “Implementation and evaluation of an innovative pharmacist-physician collaborative influenza disease state management program.” Journal of the American Pharmacist Association.  2016;56:14-21.